1-(2,6-DIFLUOROPHENYL)-3-(2-PIPERAZIN-1-YLETHYL)-1,3-DIHYDRO-2,1,3-BENZOTHIADIAZOLE 2,2-DIOXIDE
UNII PFW9A4FSE8
Substance Identification & Data
This profile provides standardized clinical and technical data for 1-(2,6-difluorophenyl)-3-(2-piperazin-1-ylethyl)-1,3-dihydro-2,1,3-benzothiadiazole 2,2-dioxide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PFW9A4FSE8.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1033221-94-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C18H20F2N4O2S YLPUPEBBKWRRQI-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1-(2,6-difluorophenyl)-3-(2-piperazin-1-ylethyl)-1,3-dihydro-2,1,3-benzothiadiazole 2,2-dioxide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.